SHANGHAI, Jan. 6, 2020 /PRNewswire/ -- InxMed (Shanghai) Co., Ltd., a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, today announced that the company has entered into a clinical collaboration with a subsidiary of...
from PR Newswire: https://ift.tt/2twvKFB
No comments:
Post a Comment